Immunochistochemical Characteristic of the Microenvironment in Squamous Cell Lung Cancer
DOI:
https://doi.org/10.14739/2310-1237.2017.2.109266Keywords:
lung neoplasms, non-small cell lung carcinoma, squamous cell carcinoma, immunohistochemistryAbstract
Tumor-associated immunocytes can influence the survival of tumor cells, the processes of proliferation and apoptosis, these immunocytes also participate in the metastatic cascade.
Aim. The purpose of this study was to estimate the features of the squamous cell lung cancer (SCLC) microenvironment using the immunohistochemical technique.
Materials and methods. Pathomorphological and immunohistochemical studies of the surgical material from 20 patients, which were treated in ZRCOD because of SCLC, were conducted: 10 patients with SCLC without metastases in the regional lymph nodes (RLN) formed the I group and 10 patients with SCLC with metastases in the RLN formed the II group.
Results. It was revealed, that the maximums of the distribution density (DD) of CD4+ and CD8+ lymphocytes are typical for the peritumorous sections of the SCLC stroma. Moreover, the statistically significant differences between the CD4+ lymphocytes DD in the stroma of the I and the II groups cases were found: 401.2 (344.6, 511.3) vs. 622.4 (587.2, 793.9) cells/mm2 in the peritumorous zones of the stroma; 298.0 (246.1, 350.1) vs. 484.8 (479.3, 690.6) cells/mm2 in the intertumorous zones of the stroma. The maximum of the CD20+ lymphocytes DD in the I group cases was revealed in the peritumorous zones of the stroma, in the II group cases – in the intertumorous zones of the stroma, while the maximum of the plasmocytes DD was observed in the intertumorous zones of the stroma. The maximum of the macrophages DD is typical for the peritumorous zones of the stroma. Moreover, there are statistically significant differences between the macrophages DD in the intertumorous zones of the stroma in the I and the II groups cases: 259.5 (193.0, 325.2) vs. 507.1 (390.2; 617.8) cells/mm2.
Conclusion. SCLC without metastasis in the RLN is characterized by the predominant distribution of CD4+, CD8+ lymphocytes and CD68+ macrophages in the peritumorous zones of the stroma, as well as CD20+ lymphocytes and plasmocytes in the intertumorous zones of the tumor stroma. SCLC with metastases in the RLN differs by the predominance of CD20+ lymphocytes in the peritumorous zones of the stroma, as well as the significantly higher values of CD4+ lymphocytes in the peri- and intertumorous zones of the stroma, CD68+ macrophages in the intertumorous zones of the tumor stroma.
References
Torre, L., Siegel, R., & Jemal, A. (2015) Global Cancer Facts & Figures. Atlanta: American Cancer Society.
Fedorenko, Z. P., Hulak, L. O., Mykhailovych, Yu. I., Horokh, E. L., Ryzhov, A. U., Sumkina, O. V., & Kutsenko, L. B. (2017). Rak v Ukraini, 2015–2016 [Cancer in Ukraine, 2015–2016]. Biulleten natsionalnoho kantser-reiestru Ukrainy, 18, 37. [in Ukrainian].
Marshall, E. A., Ng, K. W., Kung, S. H., Conway, E. M., Martinez, V. D., Halvorsen, E. C., et al. (2016) Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis. Molecular Cancer, 15(1), 67–74. doi: 10.1186/s12943-016-0551-1.
Kinoshita, T., Muramatsu, R., Fujita, T., Nagumo, H., Sakurai, T., Noji, S., et al. (2016) Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer. Annals of Oncology, 27(11), 2117–2123. doi: 10.1093/annonc/mdw319.
Banat, G. A., Tretyn, A., Pullamsetti, S. S., Wilhelm, J., Weigert, A., Olesch, C., et al. (2015) Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma. PLOS one, 10(9), e0139073. doi: 10.1371/journal.pone.0139073.
Yan, X., Jiao, S. C., Zhang, G. Q., Guan, Y., & Wang, J. L. (2017) Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer. Cancer Gene Therapy, 24(2), 57–63. doi: 10.1038/cgt.2016.40.
Lo Presti, E., Dieli, F., & Meraviglia, S. (2014) Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment. Frontiers in Immunology, 5, 608–616. doi: 10.3389/fimmu.2014.00607.
Jackutėa, J., Žemaitisa, M., & Pranysb, D. (2015) Distribution of CD4+ and CD8+ T cells in tumor islets and stroma from patients with non-small cell lung cancer in association with COPD and smoking. Medicina, 51(5), 263–271. doi: 10.1016/j.medici.2015.08.002.
Prado-Garcia, H., Romero-Garcia, S., Aguilar-Cazares, D., Meneses-Flores, M., & Lopez-Gonzalez, J. S. (2012) Tumor-Induced CD8+ T-Cell Dysfunction in Lung Cancer Patients. Journal of Immunology Research, 2012, 741741. doi: 10.1155/2012/741741.
Nelson, B. H. (2010) CD20+ B cells: the other tumor-infiltrating lymphocytes. / Nelson. The Journal of Immunology, 185(9), 4977–4982. doi: 10.4049/jimmunol.1001323.
Lohr, M., Edlund, K., Botling, J., Hammad, S., Hellwig, B., Othman, A., et al. (2013) The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer. Cancer Letters, 333(2), 222–228. doi: 10.1016/j.canlet.2013.01.036.
Fujimoto, M., Yoshizawa, A., Sumiyoshi, S., Sonobe, M., Kobayashi, M., Koyanagi, I., et al. (2013) Stromal plasma cells expressing immunoglobulin G4 subclass in non-small cell lung cancer. Human Pathology, 44(8), 1569–1576. doi: 10.1016/j.humpath.2013.01.002.
Ma, J., Liu, L., Che, G., Yu, N., Dai, F., & You, Z. (2010) The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer, 10, 112–120. doi: 10.1186/1471-2407-10-112.
Zaynagetdinov, R., Sherrill, T. P., Polosukhin, V. V., Han, W., Ausborn, J. A., McLoed, A. G., et al. (2011) A critical role for macrophages in promotion of urethane-induced lung carcinogenesis. The Journal of Immunology, 187(11), 5703–5711. doi: 10.4049/jimmunol.1100558.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).